Search filters

List of works by Alessandra Romano

A Real-Life Survey of Venous Thromboembolic Events Occurring in Myeloma Patients Treated in Third Line with Second-Generation Novel Agents

scientific article published on 05 September 2020

A snapshot of asparaginase-induced liver insufficiency.

scientific article published on 10 January 2014

Acute GVHD after allogeneic hematopoietic transplantation affects early marrow reconstitution and speed of engraftment

scientific article published on 20 February 2015

Advances in understanding regulatory myeloid cells

scientific article published on 01 June 2011

Antiproliferative and Antiangiogenic Effects of Punica granatum Juice (PGJ) in Multiple Myeloma (MM)

scientific article published on October 2016

Aplastic Anemia & MDS International Foundation (AA&MDSIF): bone marrow failure disease scientific symposium 2012.

scientific article published in May 2013

Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial

scientific article published on 31 January 2011

Bortezomib modulates CHIT1 and YKL40 in monocyte-derived osteoclast and in myeloma cells.

scientific article published on 14 October 2015

Broad copy neutral-loss of heterozygosity regions and rare recurring copy number abnormalities in normal karyotype-acute myeloid leukemia genomes.

scientific article

CD200 expression in patients with Multiple Myeloma: another piece of the puzzle.

scientific article

Childhood neurofibromatosis type 2 (NF2) and related disorders: from bench to bedside and biologically targeted therapies.

scientific article

Circulating myeloid-derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up-front with a risk-adapted strategy.

scientific article published on 7 November 2014

Clinical Benefit of Long-Term Disease Control with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients

scientific article published on 16 October 2019

Clinical Impact of the Immunome in Lymphoid Malignancies: The Role of Myeloid-Derived Suppressor Cells

scientific article

Clonal selection of 11q CN-LOH and CBL gene mutation in a serially studied patient during MDS progression to AML

scientific article published on 01 August 2010

Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients

scientific article published on 12 January 2011

Endoscopic features of gastro-intestinal lymphomas: from diagnosis to follow-up

scientific article

Endoscopic ultrasonography in gastric lymphomas: appraisal on reliability in long-term follow-up

scientific article published on 20 December 2011

Energy dynamics for systemic configurations of virus-host co-evolution

scientific article published on 15 May 2020

Erythrocytapheresis is a valid and safe therapeutic option in dysmetabolic iron overload syndrome

scientific article published on 28 September 2015

Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network

scientific article published on 19 June 2019

Granulocyte-like myeloid derived suppressor cells (G-MDSC) are increased in multiple myeloma and are driven by dysfunctional mesenchymal stem cells (MSC)

scientific article published on 7 March 2016

Heme oxygenase-1 nuclear translocation regulates bortezomibinduced cytotoxicity and mediates genomic instability in myeloma cells

scientific article

High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomib

scientific article published on February 2014

Imatinib increases cytotoxicity of melphalan and their combination allows an efficient killing of chronic myeloid leukemia cells.

scientific article published on 8 February 2011

Immune off-target effects of Brentuximab Vedotin in relapsed/refractory Hodgkin Lymphoma

scientific article published on 15 February 2019

Immunological deregulation in classic hodgkin lymphoma.

scientific article

Immunological dysregulation in multiple myeloma microenvironment.

scientific article published on 11 June 2014

Immunoproteasome Genes Are Modulated in CD34+ JAK2V617F Mutated Cells from Primary Myelofibrosis Patients

scientific article published on 22 April 2020

Inhibition of TLR4 Signaling Affects Mitochondrial Fitness and Overcomes Bortezomib Resistance in Myeloma Plasma Cells

scientific article published on 22 July 2020

Intravenous injection of bortezomib, melphalan and dexamethasone in refractory and relapsed multiple myeloma

scientific article published on 07 November 2012

Ixazomib Improves Bone Remodeling and Counteracts sonic Hedgehog signaling Inhibition Mediated by Myeloma Cells

scientific article published on 30 January 2020

Mesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia Patients

scientific article

Mitochondrial Functions, Energy Metabolism and Protein Glycosylation are Interconnected Processes Mediating Resistance to Bortezomib in Multiple Myeloma Cells

scientific article published on 30 April 2020

Monocytic Myeloid Derived Suppressor Cells in Hematological Malignancies ⬇️

scientific article published on 01 November 2019

Myeloid derived suppressor cells (MDSCs) are increased and exert immunosuppressive activity together with polymorphonuclear leukocytes (PMNs) in chronic myeloid leukemia patients.

scientific article

NF-κB localization in multiple myeloma plasma cells and mesenchymal cells.

scientific article published on 31 July 2010

Neutrophil to lymphocyte ratio (NLR) improves the risk assessment of ISS staging in newly diagnosed MM patients treated upfront with novel agents

scientific article

PMN-MDSC and arginase are increased in myeloma and may contribute to resistance to therapy.

scientific article published on 30 April 2018

Plasticity of High-Density Neutrophils in Multiple Myeloma is Associated with Increased Autophagy Via STAT3

scientific article published on 19 July 2019

Pomalidomide experience: an effective therapeutic approach with immunomodulatory drugs in a patient with relapsed-refractory multiple myeloma.

scientific article published on February 2017

Prognostic assessment and treatment of primary gastric lymphomas: how endoscopic ultrasonography can help in tailoring patient management

scientific article

Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy.

scientific article published on 14 February 2018

Proteomic Analysis Reveals Autophagy as Pro-Survival Pathway Elicited by Long-Term Exposure with 5-Azacitidine in High-Risk Myelodysplasia.

scientific article

Salvage therapy of multiple myeloma: the new generation drugs

scientific article published on 19 May 2014

Salvage therapy with pegylated liposomal doxorubicin, bortezomib, cyclophosphamide, and dexamethasone in relapsed/refractory myeloma patients.

scientific article

Standard therapies versus novel therapies in Hodgkin lymphoma.

scientific article published on September 2013

The Neutrophil-to-Lymphocyte Ratio is Related to Disease Activity in Relapsing Remitting Multiple Sclerosis

scientific article published on 20 September 2019

The Role of Inflammation and Inflammasome in Myeloproliferative Disease

scientific article published on 22 July 2020

The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study.

scientific article

The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphoma

scientific article published on 16 March 2016

The neutrophil to lymphocyte ratio (NLR) and the presence of large nodal mass are independent predictors of early response: A subanalysis of the prospective phase II PET-2-adapted HD0607 trial

scientific article published on 06 November 2020

The prognostic value of the myeloid-mediated immunosuppression marker Arginase-1 in classic Hodgkin lymphoma

scientific article published on 14 September 2016

Paulina is supported by:

About Paulina

Help